Ketamine for PTSD: What the Research Really Shows

Short answer: Ketamine for PTSD is off-label, not FDA-approved for this use, with promising but early evidence. A 2021 trial found repeated IV infusions reduced chronic PTSD symptoms more than an active placebo, while a larger 2022 trial in veterans was less clear. It likely works best alongside trauma-focused therapy, not as a standalone fix.

How PTSD keeps the alarm ringing

PTSD is less a memory problem than a fear-learning problem. After trauma, the brain stores the event with an intense threat signal, and the systems meant to update it (the danger has passed) stall. The result is a nervous system stuck on guard: intrusive memories, nightmares, avoidance, poor sleep.

The National Center for PTSD estimates about 6 in 100 people in the US will have PTSD at some point. First-line care, trauma-focused therapies such as prolonged exposure, cognitive processing therapy, and EMDR, plus two FDA-approved SSRIs (sertraline and paroxetine), helps many people. But a meaningful share improve only partly, and that group is where ketamine research has focused.

Why ketamine's mechanism is relevant

Fear memories are written and rewritten through glutamate, the brain's main excitatory messenger. Ketamine blocks NMDA receptors, setting off downstream activity linked in laboratory research to new synaptic connections. The working theory is a temporary window of flexibility, when rigid fear associations may be easier to update and the new learning trauma therapy aims for may take hold more readily.

That theory is still being tested. Better established is ketamine's rapid antidepressant effect, which matters because depression commonly travels with PTSD. Our page on PTSD treatment at Ketamine Uplift explains how we approach both.

What the evidence actually shows

The strongest single study is a 2021 Mount Sinai trial in the American Journal of Psychiatry. Thirty adults with chronic PTSD received six infusions over two weeks of either ketamine or midazolam, an active placebo. About two thirds of the ketamine group responded, versus one in five on midazolam, and infusions were generally well tolerated. The catch: among responders, benefits typically began fading within about a month after the series.

A larger 2022 trial in 158 veterans and service members whose PTSD had not responded to antidepressants was less clear: no consistent advantage over placebo on PTSD symptoms, though the standard dose improved depression scores. Reviews call the field encouraging but limited by small samples and short follow-up.

In short: worth exploring when standard care has fallen short, with real uncertainty about who benefits and for how long. Our explainer on ketamine's FDA status covers what off-label use means in practice.

How it pairs with trauma-focused therapy

If the benefit is a window of flexibility, it makes sense to use it. Researchers are now testing ketamine alongside prolonged exposure, including a VA randomized trial whose results are still emerging. Lighter symptoms can make difficult therapy work easier, the idea behind ketamine-assisted therapy in its various forms.

At Ketamine Uplift, every infusion begins with intention setting, and we encourage patients to keep their therapist closely involved throughout the Uplift Momentum Protocol.

Who it may suit, and the risks

Ketamine may be worth discussing if you have tried evidence-based therapy and medication for PTSD and remain significantly limited. We cover specific groups in ketamine therapy for veterans and PTSD in law enforcement for first responders.

Ketamine is a controlled medication and is not right for everyone. Common short-term effects include dissociation, nausea, dizziness, and temporary rises in blood pressure. For trauma survivors, dissociation can feel unsettling, which is why a calm setting and continuous monitoring matter. Uncontrolled high blood pressure, a history of psychosis, and active substance misuse are among the reasons a provider may advise against it. Our guide to ketamine therapy side effects goes deeper.

If you are having thoughts of harming yourself, please reach out now. Call or text 988, the Suicide and Crisis Lifeline, any time. Veterans can press 1 for the Veterans Crisis Line.

This article is for educational purposes only and is not medical advice. Ketamine is a controlled medication administered under medical supervision. Consult a licensed provider about your individual situation.

The bottom line

Ketamine for PTSD rests on a sensible mechanism and encouraging trials, with honest gaps in the evidence. It is off-label, not a cure, and best paired with trauma therapy. If PTSD has outlasted standard care, a complimentary telehealth evaluation with Dr. O'Neill can help you weigh the fit. Call us at (310) 280-4440.

Frequently asked questions

Is ketamine FDA-approved for PTSD? No. Ketamine is FDA-approved as an anesthetic, and its use for PTSD is off-label. Spravato (esketamine) is approved for depression, not PTSD.

How quickly can ketamine help PTSD symptoms? In the 2021 Mount Sinai trial, improvement often appeared within the two-week series. Response varies, and some people do not respond.

How long do the benefits last? In research, gains often faded within weeks without further treatment. Boosters and ongoing therapy are often used to extend results.

Can ketamine replace trauma therapy? No. Evidence-based trauma therapy remains the foundation of PTSD care, and ketamine is best viewed as a possible support for that work.